Loredana Alletto is the Chief Operating Officer of Regensight.
She will lead the strategies and operations of Regensight, consistently with the objective of affirming the new paradigm of theranostics for predictive and precision treatment of keratoconus. She will also be responsible for developing and consolidating relationships with institutional and private stakeholders.
Graduated in Biology, Loredana Alletto has developed her professionalism in over thirty years of experience in the field of Life Science in multinational companies including Organon, Wyeth and Pfizer. In her career, she has overseen the introduction and affirmation of successful products in various therapeutic areas including cardiovascular (Lipitor), urology (Viagra), ophthalmology, endocrinology, gynecology and rare diseases.
From all the Regensight Team, Welcome Loredana!